| Product Code: ETC9979217 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Vulvovaginal Candidiasis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Vulvovaginal Candidiasis Market - Industry Life Cycle |
3.4 United States (US) Vulvovaginal Candidiasis Market - Porter's Five Forces |
3.5 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Vulvovaginal Candidiasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about vulvovaginal candidiasis among women |
4.2.2 Rising incidences of vaginal yeast infections |
4.2.3 Growing demand for over-the-counter antifungal medications |
4.3 Market Restraints |
4.3.1 Availability of alternative treatment options |
4.3.2 Side effects associated with antifungal medications |
4.3.3 Lack of proper diagnosis and treatment |
5 United States (US) Vulvovaginal Candidiasis Market Trends |
6 United States (US) Vulvovaginal Candidiasis Market, By Types |
6.1 United States (US) Vulvovaginal Candidiasis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Miconazole, 2021- 2031F |
6.1.4 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Clotrimazole, 2021- 2031F |
6.1.5 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Fluconazole, 2021- 2031F |
6.1.6 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Econazole, 2021- 2031F |
6.1.7 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Other, 2021- 2031F |
6.2 United States (US) Vulvovaginal Candidiasis Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Hospital & Clinic, 2021- 2031F |
6.2.3 United States (US) Vulvovaginal Candidiasis Market Revenues & Volume, By Pharmacy, 2021- 2031F |
7 United States (US) Vulvovaginal Candidiasis Market Import-Export Trade Statistics |
7.1 United States (US) Vulvovaginal Candidiasis Market Export to Major Countries |
7.2 United States (US) Vulvovaginal Candidiasis Market Imports from Major Countries |
8 United States (US) Vulvovaginal Candidiasis Market Key Performance Indicators |
8.1 Number of visits to healthcare providers for vulvovaginal candidiasis symptoms |
8.2 Percentage of women seeking treatment for recurrent yeast infections |
8.3 Rate of prescription of antifungal medications by healthcare professionals |
9 United States (US) Vulvovaginal Candidiasis Market - Opportunity Assessment |
9.1 United States (US) Vulvovaginal Candidiasis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Vulvovaginal Candidiasis Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Vulvovaginal Candidiasis Market - Competitive Landscape |
10.1 United States (US) Vulvovaginal Candidiasis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Vulvovaginal Candidiasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here